ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Innovation Pharmaceuticals Doses First Cohort of Oral Brilacidin for Ulcerative Colitis
January 19, 2020Innovation Pharmaceuticals has dosed the first cohort in its Phase 1 trial to investigate the use of delayed release tablets for colonic delivery of Brilacidin in healthy volunteers. This study formally launches the Company’s clinical program in Ulcerativ -
Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors From F
December 28, 2017Innovation Pharmaceuticals Announces Preliminary Results of Kevetrin's First Phase 2a Clinical Trial in Ovarian Cancer Therapy (see NCT03042702) Preliminary data encouraging.
Pharma Sources Insight January 2025
